Not Yet RecruitingPhase 4

Use of Misoprostol in Hysteroscopic Myomectomy

Israel200 participantsStarted 2023-11

Plain-language summary

Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.

Who can participate

Age range20 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women between the ags of 20 years- 55 years, inclusive * undergoing hysteroscopic myomectomy * submucosal fibroid less than 40 mm (type 0, 1 and 2) * up to 2 submucosal fibroids * patients are able to provide written informed consent Exclusion Criteria: * post menopausal women * inability to perform operative hysteroscopy under anesthesia in the past due to cervical stenosis * previous PID or documented tubal occlusion * positive BHCG test * inability to consent due to cognitive or language barrier * allergy to misoprostole * severe COPD, asthma or cardiac disease

What they're measuring

length of the procedure

Timeframe: from the first insertion of the hysteroscope to the end of the procedure, minutes

Trial details

NCT IDNCT06049745

SponsorAssuta Ashdod Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08

Contact for this trial

oshri barel

972 55 938 2117 oshrib@assuta.co.il

View on ClinicalTrials.gov More Hysteroscopic Myomectomy trials